These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31751326)

  • 81. Case of e-cigarette or vaping product use-associated lung injury (EVALI) in London, UK.
    Evans RE; Herbert S; Owen W; Rao D
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33837028
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Case series: Adolescent victims of the vaping public health crisis with pulmonary complications.
    Kass AP; Overbeek DL; Chiel LE; Boyer EW; Casey AMH
    Pediatr Pulmonol; 2020 May; 55(5):1224-1236. PubMed ID: 32168438
    [TBL] [Abstract][Full Text] [Related]  

  • 83. E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Continues: An Opportunity for Pharmacist Intervention.
    Andrus MR
    Ann Pharmacother; 2024 May; 58(5):549-554. PubMed ID: 37605427
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest.
    Wackowski OA; Gratale SK; Jeong M; Delnevo CD; Steinberg MB; O'Connor RJ
    Tob Control; 2023 Aug; 32(e2):e255-e259. PubMed ID: 35228318
    [TBL] [Abstract][Full Text] [Related]  

  • 85. E-cigarette or Vaping product use Associated Lung Injury (EVALI): Health issues going beyond anaesthetic and surgical perioperative procedures.
    Stoebner A; Le Faou AL; Huteau ME; Gricourt Y; Cuvillon P
    Anaesth Crit Care Pain Med; 2019 Dec; 38(6):563-564. PubMed ID: 31785695
    [No Abstract]   [Full Text] [Related]  

  • 86. Analysis of state portrayals of the risks of e-cigarette use and the cause of the EVALI outbreak.
    Katchmar A; Shafer P; Siegel M
    Harm Reduct J; 2022 Oct; 19(1):112. PubMed ID: 36199112
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Electronic Cigarettes and Vaping-Associated Lung Injury (EVALI): A Rural Appalachian Experience.
    Sangani R; Rojas E; Forte M; Zulfikar R; Prince N; Tasoglou A; Goldsmith T; Casuccio G; Boyd J; Olfert IM; Flanagan M; Sharma S
    Hosp Pract (1995); 2021 Apr; 49(2):79-87. PubMed ID: 33136442
    [No Abstract]   [Full Text] [Related]  

  • 88. Vaping-associated lung illness (VALI) in Canada: a descriptive analysis of VALI cases reported from September 2019 to December 2020.
    Baker MM; Procter TD; Belzak L; Ogunnaike-Cooke S
    Health Promot Chronic Dis Prev Can; 2022 Jan; 42(1):37-44. PubMed ID: 35044143
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Electronic cigarettes and e-cigarette/vaping product use associated lung injury (EVALI).
    Shinbashi M; Rubin BK
    Paediatr Respir Rev; 2020 Nov; 36():87-91. PubMed ID: 32653465
    [TBL] [Abstract][Full Text] [Related]  

  • 90. E-cigarette or Vaping Product Use-Associated Lung Injury Complicated by Pulmonary Aspergillosis.
    Kupelian C; Kim A; Vijayan V
    Cureus; 2021 Dec; 13(12):e20075. PubMed ID: 34987937
    [TBL] [Abstract][Full Text] [Related]  

  • 91. State marijuana policies and vaping associated lung injuries in the US.
    Friedman AS; Morean ME
    Drug Alcohol Depend; 2021 Nov; 228():109086. PubMed ID: 34600265
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Using a mixed methods approach to identify public perception of vaping risks and overall health outcomes on Twitter during the 2019 EVALI outbreak.
    Kasson E; Singh AK; Huang M; Wu D; Cavazos-Rehg P
    Int J Med Inform; 2021 Nov; 155():104574. PubMed ID: 34592539
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Significance of Oil-Red-O positive macrophages in bronchoalveolar lavage in diagnosing E-cigarettes or vaping product use-associated lung injury: A case series.
    Niu S; Colon GR; Molberg K; Chen H; Carrick K; Yan S; Sarode V; Lucas E
    Diagn Cytopathol; 2021 Jul; 49(7):876-884. PubMed ID: 33900686
    [TBL] [Abstract][Full Text] [Related]  

  • 94. E-cigarette or vaping product use-associated lung injury in the pediatric population: imaging features at presentation and short-term follow-up.
    Wang KY; Jadhav SP; Yenduri NJS; Lee SA; Farber HJ; Guillerman RP
    Pediatr Radiol; 2020 Aug; 50(9):1231-1239. PubMed ID: 32495177
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Vaping-Associated Lung Injury During COVID-19 Multisystem Inflammatory Syndrome Outbreak.
    Hassoun A; Brady K; Arefi R; Trifonova I; Tsirilakis K
    J Emerg Med; 2021 Apr; 60(4):524-530. PubMed ID: 33483200
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Google shopping queries for vaping products, JUUL and IQOS during the E-cigarette, or Vaping, product use Associated Lung Injury (EVALI) outbreak.
    Leas EC; Moy NH; Nobles AL; Ayers J; Zhu SH; Purushothaman V
    Tob Control; 2022 Aug; 31(e1):e74-e77. PubMed ID: 33608466
    [TBL] [Abstract][Full Text] [Related]  

  • 97. E-cigarette, or vaping, product use-associated lung injury: a review.
    Belok SH; Parikh R; Bernardo J; Kathuria H
    Pneumonia (Nathan); 2020; 12():12. PubMed ID: 33110741
    [TBL] [Abstract][Full Text] [Related]  

  • 98. E-cigarette or vaping induced lung injury: A case series and literature review.
    Doukas SG; Kavali L; Menon RS; Izotov BN; Bukhari A
    Toxicol Rep; 2020; 7():1381-1386. PubMed ID: 33102141
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pulmonary Function Testing in Patients With E-Cigarette, or Vaping, Product Use-Associated Lung Injury.
    Wei X; Iakovou A; Makaryus MR; Khanijo S
    Cureus; 2021 Aug; 13(8):e17019. PubMed ID: 34522500
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury.
    Hartnett KP; Kite-Powell A; Patel MT; Haag BL; Sheppard MJ; Dias TP; King BA; Melstrom PC; Ritchey MD; Stein Z; Idaikkadar N; Vivolo-Kantor AM; Rose DA; Briss PA; Layden JE; Rodgers L; Adjemian J
    N Engl J Med; 2020 Feb; 382(8):766-772. PubMed ID: 31860794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.